Schonfeld Strategic Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-13,114
| Closed | -$94K | – | 1626 |
|
|
2020
Q1 | $94K | Buy |
13,114
+2,903
| +28% | +$20.8K | 0.01% | 1009 |
|
|
2019
Q4 | $244K | Sell |
10,211
-116,754
| -92% | -$2.79M | 0.01% | 1073 |
|
|
2019
Q3 | $3.41M | Buy |
126,965
+25,365
| +25% | +$680K | 0.1% | 218 |
|
|
2019
Q2 | $2.76M | Sell |
101,600
-141,690
| -58% | -$3.84M | 0.1% | 237 |
|
|
2019
Q1 | $8.44M | Buy |
243,290
+133,890
| +122% | +$4.65M | 0.29% | 90 |
|
|
2018
Q4 | $2.14M | Buy |
109,400
+51,700
| +90% | +$1.01M | 0.08% | 308 |
|
|
2018
Q3 | $1.54M | Buy |
57,700
+32,600
| +130% | +$868K | 0.07% | 340 |
|
|
2018
Q2 | $948K | Buy |
+25,100
| New | +$948K | 0.05% | 403 |
|
|
2018
Q1 | – | Sell |
-9,279
| Closed | -$451K | – | 1031 |
|
|
2017
Q4 | $451K | Buy |
+9,279
| New | +$451K | 0.04% | 486 |
|
|
2017
Q3 | – | Sell |
-20,990
| Closed | -$1.18M | – | 825 |
|
|
2017
Q2 | $1.18M | Buy |
+20,990
| New | +$1.18M | 0.12% | 241 |
|
|
2016
Q3 | – | Sell |
-12,043
| Closed | -$285K | – | 600 |
|
|
2016
Q2 | $285K | Buy |
+12,043
| New | +$285K | 0.06% | 322 |
|